Ursula Matulonis, M.D., professor of Medicine, Harvard Medical School, Medical Director of Gynecologic Oncology, Dana-Farber Cancer Institute, explains the benefits of PARP inhibitors for patients with ovarian cancer.
Ursula Matulonis, M.D.
Advertisement
Articles by Ursula Matulonis, M.D.
Advertisement
Latest Updated Articles
Ursula Matulonis Explains the Use of PARP Inhibitors for Ovarian CancerPublished: March 13th 2017 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Body Image and Sexual Health Challenges After Breast Cancer
2
What Libtayo Means for High-Risk Cutaneous Squamous Cell Carcinoma
3
Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery
4
What Are Non-Muscle Invasive Bladder Cancer and its Treatment Options?
5
